ClinVar Miner

Submissions for variant NM_000192.3(TBX5):c.668C>T (p.Thr223Met) (rs1555225344)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000519158 SCV000616887 pathogenic not provided 2017-10-30 criteria provided, single submitter clinical testing The T223M variant has been published previously in association with Holt-Oram syndrome (Brassington et al., 2003; McDermott et al., 2005). The variant is not observed in large population cohorts (Lek et al., 2016). T223M is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Functional studies have shown that T223M interferes with the normal DNA-binding of the TBX5 protein (Stirnimann et al., 2010). In summary, we consider this variant to be pathogenic.
Invitae RCV000654913 SCV000776817 pathogenic Aortic valve disease 2 2019-07-15 criteria provided, single submitter clinical testing This sequence change replaces threonine with methionine at codon 223 of the TBX5 protein (p.Thr223Met). The threonine residue is highly conserved and there is a moderate physicochemical difference between threonine and methionine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals with Holt-Oram Syndrome and has been shown to segregate with disease in affected families (PMID: 12789647, 16183809 ). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). For these reasons, this variant has been classified as Pathogenic.
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille RCV000782334 SCV000920855 likely pathogenic Holt-Oram syndrome 2018-06-14 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.